US Stock MarketDetailed Quotes

IVVD Invivyd

Watchlist

1.220
+0.070+6.09%

Close Jul 22 16:00 ET

145.57MMarket Cap-652P/E (TTM)

Invivyd Stock Forum

Trytosaveabit

May 31 06:23

Update

$Invivyd(IVVD.US)$ Invivyd Announces General Alignment with U.S. FDA on a Repeatable, Expedient Emergency Use Authorization Pathway for the Prevention and Treatment of Symptomatic COVID-19, Based on Compact Clinical Programs to Establish Safety and Immunobridging for Serial Monoclonal Antibodies
• Newly outlined pathway provides a practical, expedient, repeatable immunobridging approach to potential emergency use authorization of serial, novel monoclonal antibodies (mAbs) to prevent and t...

Jaguar8

May 29 06:17

NEWS

$Invivyd(IVVD.US)$
Invivyd to Present Data at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and 2024 American Transplant Congress (ATC)
Invivyd announced its upcoming presentations at the 2024 ASCO Annual Meeting and the 2024 ATC. The presentations will cover preliminary subset analyses from the Phase 3 CANOPY trial of VYD222 (pemivibart), a monoclonal antibody aimed at preventing COVID-19.
At ASCO (May 31 – June 4, Chicago, IL), the focus will be on participants with sign...

Trytosaveabit

May 7 06:40

Update

$Invivyd(IVVD.US)$ Benzinga· just
Invivyd To Pursue Rapid Immunobridging Pathway To Potential EUA For Treatment Of COVID-19 In Moderately To Severely Immunocompromised People, Based On U.S. FDA Feedback

Trytosaveabit

Apr 15 06:35

Update

$Invivyd(IVVD.US)$ Invivyd Receives Healthcare Common Procedure Coding System (Hcpcs) Reimbursement Codes From the U.S. Centers for Medicare & Medicaid Services (CMS) Covering Pemgarda™

Trytosaveabit

Apr 5 07:26

$Invivyd(IVVD.US)$ Invivyd Shares Are Trading Higher After the Company Announced PEMGARDA Is Available for Purchase in the U.S. and Said It Sees Initial FY24 PEMGARDA Net Product Revenue Guidance in the Range of $150 Million to $200 Million